Charlotte Jones-Burton
Director/Board Member at BLUEBIRD BIO, INC.
Net worth: 16 947 $ as of 2024-04-29
Profile
Charlotte Jones-Burton is the founder of Women of Color in Pharma.
She is currently an Independent Director at bluebird bio, Inc. .
She previously worked as the VP, Global Head-Clinical Development & Nephrology at Otsuka Pharmaceutical Development & Commercialization, Inc. and as the VP-Global Clinical Development & Head-Nephrology at Otsuka Pharmaceuticals (U.K.) Ltd.
In 2022, she held the position of Senior VP-Product Development & Strategy at Chinook Therapeutics, Inc. Dr. Jones-Burton completed her undergraduate studies at Washington University in St. Louis.
She also obtained graduate and doctorate degrees from the University of Maryland School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.01% | 2023-06-15 | 18,562 ( 0.01% ) | 16 947 $ | 2024-04-29 |
Charlotte Jones-Burton active positions
| Companies | Position | Start |
|---|---|---|
| BLUEBIRD BIO, INC. | Director/Board Member | 2022-03-06 |
| Women of Color in Pharma | Founder | - |
Former positions of Charlotte Jones-Burton
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-10-01 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Corporate Officer/Principal | - |
Training of Charlotte Jones-Burton
| Washington University in St. Louis | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
Otsuka Pharmaceuticals (U.K.) Ltd.
Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
| Women of Color in Pharma |
- Stock Market
- Insiders
- Charlotte Jones-Burton
